Skip to content

Clinical trials

Completed Phase 2 Parkinson Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 2 Status: Completed Clear all

279 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20012
20026
200311
200414
200511
200616
200716
20086
200911
201016
201115
201214
20137
20149
20159
201618
201713
201814
20198
202011
202114
20227
202310
20246
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed279

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)17
Institute for Neurodegenerative Disorders8
Chang Gung Memorial Hospital7
Kyowa Kirin Co., Ltd.6
Novartis5
Novartis Pharmaceuticals5
Bial - Portela C S.A.4
Biogen4
Impax Laboratories, LLC4
University Hospital, Toulouse4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease279
Dyskinesias29
Movement Disorders15
Neurodegenerative Diseases8
Parkinsonian Disorders8
Brain Diseases5
Central Nervous System Diseases5
Disorders of Excessive Somnolence5
Psychotic Disorders5
Tremor5

Trials

Showing 1 to 25 of 279. Each trial links to its page on Pharma Observatory.

179 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.